Rishav Das

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• Emerging therapeutic strategies for triple-negative breast cancer using ruthenium, iridium, and rhenium complexes
  Dalton Transactions 2026 DOI: 10.1039/d6dt01362g
  +Save
• Turning Off the Powerhouse: Mitochondria-Targeted DPPZ-Ru(II)/Ir(III)/Re(I) Complexes Trigger Dual Mitophagy and Apoptosis To Halt Triple-Negative Breast Cancer
  Utpal Das, Shanooja Shanavas, Shubhangi More +12 more
  Journal of Medicinal Chemistry 2026 DOI: 10.1021/acs.jmedchem.5c02210
  +Save
• Butterfly-like photo-responsive cyclometalated Ir(iii) complex: emergence of a future cancer therapeutic agent
  U Sreelekha, Rishav Das, Indrani Paramasivan Latha Laxmi

  +6 more

  • Nilmadhab Roy
  • Riona Roy
  • Logesh Mathivathanan
  • Ramasamy Tamizhselvi
  • Rinku Chakrabarty
  • +1 more
  Dalton Transactions 2025 DOI: 10.1039/d5dt01164g
  +Save
• Dual functioning Ru(ii)/Ir(iii) complexes for ferroptosis and apoptosis in triple-negative breast cancer: a proof of concept by glutathione depletion
  Utpal Das, Tiasha Dasgupta, Krishna Santhoshkumar +11 more
  Dalton Transactions 2025 DOI: 10.1039/d5dt01428j
  +Save
• Rhodamine: Promising Theranostic Agent in Cancer Therapy
  Rishav Das, Sreejani Ghosh, Priyankar Paira

  +1 more

  • Rinku Chakrabarty
  Chemistry an Asian Journal 2025 DOI: 10.1002/asia.202500771
  +Save
• Synthesis, characterization, biomolecular interaction, potent aqueous singlet oxygen generation and NADH photo-oxidation of phenanthroline-based cyclometalated Ir(iii) complexes
  Bhumika Joshi, Rishav Das, Rinku Chakrabarty

  +2 more

  • Murugesh Shivashankar
  • Priyankar Paira
  Rsc Advances 2025 DOI: 10.1039/d5ra06269a
  +Save
• The role of ancillary ligands on benzodipyridophenazine-based Ru(ii)/Ir(iii) complexes in dark and light toxicity against TNBC cells
  T. Nivedya, Rishav Das, Selva Kumar Ramasamy +9 more
  Dalton Transactions 2025 DOI: 10.1039/d4dt03456b
  +Save
• Turning the Spotlight Away from PDT: Chemodynamic Dominance of 2-(2-Bromopyridin-4-yl)-1H-imidazo[4,5-f][1,10]phenanthroline Based Ru(II)/Ir(III)/Re(I) Complexes against MDA-MB-231
  Rishav Das, Shanooja Shanavas, Utpal Das +7 more
  Journal of Medicinal Chemistry 2025 DOI: 10.1021/acs.jmedchem.5c02400
  +Save
• A Glance on target specific PDT active cyclometalated iridium complexes
  Rishav Das, Ushasi Das, Nilmadhab Roy

  +3 more

  • Chandrapaul Mukherjee
  • U Sreelekha
  • Priyankar Paira
  Dyes and Pigments 2024 DOI: 10.1016/j.dyepig.2024.112134
  +Save
• Re(i)[2-aryl-1H-imidazo[4,5-f][1,10]phenanthroline] tricarbonyl chloride complexes for selective cancer therapy via a potential DNA damage mechanism
  Lavanya Thilak Babu, Utpal Das, Rishav Das +2 more
  Dalton Transactions 2024 DOI: 10.1039/d3dt04383e
  +Save
• Different routes for the construction of biologically active diversely functionalized bicyclo[3.3.1]nonanes: an exploration of new perspectives for anticancer chemotherapeutics
  Nilmadhab Roy, Rishav Das, Rupankar Paira +1 more
  Rsc Advances 2023 DOI: 10.1039/d3ra02003g
  +Save
• GSH resistant, luminescent 2-(pyren-1-yl)-1H-imidazo[4,5-f][1,10]phenanthroline-based Ru(ii)/Ir(iii)/Re(i) complexes for phototoxicity in triple-negative breast cancer cells
  Dalton Transactions 2023 DOI: 10.1039/d3dt01667f
  +Save